Emerging role of PTEN loss in evasion of the immune response to tumours (2020)
- Authors:
- USP affiliated authors: SQUIRE, JEREMY ANDREW - FMRP ; REIS, RODOLFO BORGES DOS - FMRP ; MELO, CAMILA MORAIS - FMRP
- Unidade: FMRP
- DOI: 10.1038/s41416-020-0834-6
- Subjects: GENÉTICA; NEOPLASIAS; BIOMARCADORES; IMUNOTERAPIA; MUTAÇÃO; IMUNOLOGIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: British Journal of Cancer
- ISSN: 0007-0920
- Volume/Número/Paginação/Ano: v. 122, p. 1732-1743, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by
-
ABNT
VIDOTTO, Thiago et al. Emerging role of PTEN loss in evasion of the immune response to tumours. British Journal of Cancer, v. 122, p. 1732-1743, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41416-020-0834-6. Acesso em: 16 abr. 2024. -
APA
Vidotto, T., Melo, C. M., Castelli, E. C., Koti, M., Reis, R. B. dos, & Squire, J. A. (2020). Emerging role of PTEN loss in evasion of the immune response to tumours. British Journal of Cancer, 122, 1732-1743. doi:10.1038/s41416-020-0834-6 -
NLM
Vidotto T, Melo CM, Castelli EC, Koti M, Reis RB dos, Squire JA. Emerging role of PTEN loss in evasion of the immune response to tumours [Internet]. British Journal of Cancer. 2020 ; 122 1732-1743.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1038/s41416-020-0834-6 -
Vancouver
Vidotto T, Melo CM, Castelli EC, Koti M, Reis RB dos, Squire JA. Emerging role of PTEN loss in evasion of the immune response to tumours [Internet]. British Journal of Cancer. 2020 ; 122 1732-1743.[citado 2024 abr. 16 ] Available from: https://doi.org/10.1038/s41416-020-0834-6 - Risk stratification of prostate cancer through quantitative assessment of PTEN loss (qPTEN)
- Quantitative measurement of PTEN loss improves risk assessment in prostate cancer
- Epithelial–mesenchymal transition signaling and prostate cancer stem cells: emerging biomarkers and opportunities for precision therapeutics
- The role of somatic mutations on the immune response of the tumor microenvironment in prostate cancer
- Envolvimento das galectinas na angiogênese tumoral em modelo de melanoma murino e associação com o microambiente tumoral via receptores toll-like
- TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
Informações sobre o DOI: 10.1038/s41416-020-0834-6 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003028702.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
